Canopy, the first Continuous Care Platform for oncology, today announced a multi-year partnership with Texas Oncology, one of the nation’s largest community-based oncology practices, encompassing nearly 1,000 providers across 280 locations in Texas. Building on the success of an initial pilot at Texas Oncology’s Amarillo Cancer Center, the collaboration will extend Canopy’s advanced platform to deliver enhanced, proactive care for patients across the Texas Oncology Network.
“Oncologists are seeing the fastest rate of therapeutic innovation in history. With this growing complexity, our practice must also evolve,” said R. Steven Paulson, MD, President and CEO of Texas Oncology. “This partnership with Canopy ensures that we remain at the forefront of cancer care, allowing us to set new standards in our approach to each patient’s unique journey.”
Debra Patt, MD, PhD, MBA, Executive Vice President of Public Policy and Strategy for Texas Oncology, added, “Oncology practices today encounter significant hurdles in expanding care outside the clinic—from technology limitations to interoperability challenges and reimbursement constraints. We have observed a positive impact on both patient outcomes and operational efficiency from Canopy. By leveraging Canopy’s AI-native automation and clinical decision support tools, we aim to improve care delivery while easing the administrative burden on our teams.”
Presentations highlighting the potential impact of Canopy’s platform on oncology patient experience in real-world settings have demonstrated:
- 45% improvement in treatment persistence at three months1 [ASCO, 2022]
- 22% reduction in ER visits/hospitalizations per 100 patient months2 [ASCO, 2022]
- 88% patient engagement sustained at six months3 [JCO, 2022]
Most recently, at the 2024 American Society of Hematology (ASH) meeting, Canopy presented new data highlighting:
- 37% reduction in treatment discontinuation at three months4 [ASH, 2024]
- Improved early detection of toxicities with bispecific antibody therapies5 [ASH, 2024]
Canopy supports care teams by capturing any issues patients might be experiencing between visits, streamlining care to drive rapid issue resolution, and enabling the capture of meaningful reimbursement through programs like Principal & Chronic Care Management (PCM/CCM) and Remote Therapeutic Monitoring (RTM).
To ensure a seamless experience between the systems care teams use daily, Canopy has also integrated with iKnowMed, Ontada’s award-winning electronic health record (EHR), by becoming a member of the Ontada Developer Marketplace. Part of McKesson’s suite of oncology solutions, Ontada enhances clinician experiences with innovative EHR technology and an open ecosystem.
“Partnering with Texas Oncology is a pivotal step in our mission to make continuous care the standard for all patients with cancer,” said Lavi Kwiatkowsky, CEO and Founder of Canopy. “Texas Oncology’s forward-thinking approach and dedication to embracing innovation make them an ideal partner. Together, we aim to set a new benchmark for AI-powered, continuous oncology care.”
Explore AITechPark for the latest advancements in AI, IOT, Cybersecurity, AITech News, and insightful updates from industry experts!